Episode 17: Challenges of developing DMOADs
Update: 2025-03-28
Description
Why are disease-modifying treatments for osteoarthritis such a difficult proposition?
"Current treatments for osteoarthritis mostly provide symptomatic relief, and so disease-modifying drugs that target the underlying structural damage would be a game changer. But despite multiple attempts, no DMOAD is yet approved for clinical use.
Prof. Ali Mobasheri takes us through the main challenges, the work being done to address them to make these so-called utopia drugs a reality, and other advances that can offer some hope in the meantime."
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
